Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WASH complex subunit 4 (WASHC4, also known as SWIP or KIAA1033) is an essential protein subunit of the pentameric WASH complex, which is necessary for the proper sorting and trafficking of proteins within endosomes[1][2]. Its main function is to stimulate localized actin polymerization by activating the Arp2/3 complex, which is crucial for the formation and fission of transport tubules from endosomes[1][2]. WASHC4 helps anchor the WASH complex to endosomal membranes by binding specific phosphoinositides (notably PI[3,5]P2), thereby regulating both retromer-dependent and retromer-independent endosomal sorting pathways[1]. It also interacts with endocytic adaptor and clathrin machinery proteins to couple endocytosis with membrane trafficking[1][2]. Mutations in WASHC4 destabilize the entire WASH complex, resulting in severe endo-lysosomal dysfunction, and have been linked to autosomal recessive intellectual developmental disorder (MRT43) and are implicated in neurodegenerative phenotypes in preclinical models[1][3][5]. There are currently no known drugs targeting WASHC4, and it is not considered a direct therapeutic target (such as a receptor or enzyme)[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WASH complex subunit 4 (WASHC4).